These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18799057

  • 21. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U.
    Am J Respir Crit Care Med; 2006 Jan 15; 173(2):180-7. PubMed ID: 16224107
    [Abstract] [Full Text] [Related]

  • 22. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
    Wawrzycka-Adamczyk K, Zugaj A, Włudarczyk A, Kosałka J, Sznajd J, Bazan-Socha S, Musiał J.
    Przegl Lek; 2014 Jan 15; 71(12):663-5. PubMed ID: 25951692
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. B-cell-targeted therapy in systemic vasculitis.
    Lally L, Spiera R.
    Curr Opin Rheumatol; 2016 Jan 15; 28(1):15-20. PubMed ID: 26599379
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B, Aouba A, Pagnoux C, Cohen P, Lacassin F, Guillevin L.
    Clin Exp Rheumatol; 2007 Jan 15; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [Abstract] [Full Text] [Related]

  • 28. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun 15; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 29. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC, Fritz J, Koch S, Klein R, Horger M, Risler T, Kanz L, Koetter I.
    Clin Rheumatol; 2007 Oct 15; 26(10):1711-5. PubMed ID: 17502992
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG, Skopouli FN.
    Clin Exp Rheumatol; 2006 Oct 15; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract] [Full Text] [Related]

  • 32. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
    Omdal R, Wildhagen K, Hansen T, Gunnarsson R, Kristoffersen G.
    Scand J Rheumatol; 2005 Oct 15; 34(3):229-32. PubMed ID: 16134730
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?
    Szilasi M, Mátyus J, File I, Szücs G, Rákóczi E, Pfliegler G, Szabó Z, Végh E, Szekanecz Z.
    Autoimmunity; 2012 Jun 15; 45(4):304-9. PubMed ID: 22443800
    [Abstract] [Full Text] [Related]

  • 35. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN, Woronik V, Halpern AS, Barbas CS.
    J Bras Pneumol; 2011 Jun 15; 37(6):809-16. PubMed ID: 22241040
    [Abstract] [Full Text] [Related]

  • 36. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA, Wylam ME, Stone JH, Specks U.
    Arthritis Rheum; 2005 Jan 15; 52(1):262-8. PubMed ID: 15641078
    [Abstract] [Full Text] [Related]

  • 37. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B, Szechiński J, Roszkowska E.
    Pol Arch Med Wewn; 2008 Jun 15; 118(6):381-5. PubMed ID: 18619196
    [Abstract] [Full Text] [Related]

  • 38. Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype?
    Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, Harabuchi Y, Kobayashi S, Suzuki K, Hashimoto H.
    Nephrol Dial Transplant; 2008 Dec 15; 23(12):3928-31. PubMed ID: 18565978
    [Abstract] [Full Text] [Related]

  • 39. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
    Reinhold-Keller E, Tatsis E, Gross WL.
    Z Rheumatol; 1995 Dec 15; 54(5):303-9. PubMed ID: 8578886
    [Abstract] [Full Text] [Related]

  • 40. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
    Minami R, Miyamura T, Watanabe H, Takahama S, Yamamoto M, Suematsu E.
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr 15; 30(2):133-8. PubMed ID: 17473516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.